Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease)
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 6, 2008
CompletedFirst Posted
Study publicly available on registry
May 8, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedAugust 17, 2009
August 1, 2009
1 year
May 6, 2008
August 14, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Therapy for FTD patients
1 year
Secondary Outcomes (1)
Rehabilitation of FTD Patients
1 Year
Study Arms (1)
1
EXPERIMENTALRadiation: Far Infrared Radiation (5μm to 20μm wavelength)
Interventions
Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
Eligibility Criteria
You may qualify if:
- People with Pick's Disease
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Centre for Incurable Diseases
Toronto, Ontario, M4V 1L5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ken Nedd, M.D.
GAAD Medical Research Institute Inc.
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 6, 2008
First Posted
May 8, 2008
Study Start
May 1, 2008
Primary Completion
May 1, 2009
Study Completion
October 1, 2009
Last Updated
August 17, 2009
Record last verified: 2009-08